
Sign up to save your podcasts
Or
In this week’s View, Dr. Eagle discusses the Fitbit Heart Study that examines the detection of atrial fibrillation in a large population using wearable devices, then looks at the long-term effects of P2Y12 inhibitor monotherapy after percutaneous coronary intervention. Finally, Dr. Eagle discusses risk assessment of hypertensive events during pregnancy.
Subscribe to Eagle’s Eye View
4.7
127127 ratings
In this week’s View, Dr. Eagle discusses the Fitbit Heart Study that examines the detection of atrial fibrillation in a large population using wearable devices, then looks at the long-term effects of P2Y12 inhibitor monotherapy after percutaneous coronary intervention. Finally, Dr. Eagle discusses risk assessment of hypertensive events during pregnancy.
Subscribe to Eagle’s Eye View
130 Listeners
324 Listeners
159 Listeners
865 Listeners
493 Listeners
32 Listeners
278 Listeners
87 Listeners
1,086 Listeners
60 Listeners
39 Listeners
185 Listeners
348 Listeners
423 Listeners
37 Listeners